Table 1.
Trial/study | Author; journal; year | No. of patients | Parameter | Endpoint | Impact on HF hospitalisation |
---|---|---|---|---|---|
TEN-HMS [5] |
Cleland et al.; J Am Coll Cardiol; 2005 |
426 | Signs/symptoms, daily weights, BP, nurse telephone calls | HF hospitalisation | Non-significant |
TELE-HF [4] |
Chaudhry et al.; N Engl J Med; 2010 |
1653 | Signs/symptoms, daily weights | HF hospitalisation | Non-significant |
TIM-HF [7] |
Koehler F et al.; Circulation; 2011 |
710 | Signs/symptoms, daily weights | HF hospitalisation | Non-significant |
INH [3] |
Angermann et al.; Circ Heart Fail; 2012 |
715 | Signs, symptoms, telemonitoring nurse coordinated | HF hospitalisation | Non-significant |
WISH [10] |
Lynga et al.; Eur J Heart Fail; 2012 |
344 | Daily weights | HF hospitalisation | Non-significant |
CHAT [9] |
Krum et al.; Cardiovasc Ther; 2013 |
405 | Monthly telephone‐based automated telemedicine system | HF hospitalisation | Non-significant |
BEAT-HF [11] |
Ong et al.; JAMA Intern Med; 2016 |
1437 | Signs, symptoms, daily weights, nurse communications | HF hospitalisation | Non-significant |
TIM-HF2 [6] |
Koehler F et al.; Lancet; 2018 |
1571 | Web-based remote monitoring on daily weight, BP, pulse, ECG, peripheral capillary oxygen saturation, a self-related health status. ECG and BP machine at home | Reduction in the weighted average of ‘the % of days lost due to unplanned CV hospital admissions or death’ | HR 0.80; 95% CI 0.65–1.00 |
BP blood pressure, CV cardiovascular, ECG electrocardiography
aDemonstrating the landmark trials only, sample size >250 patients, discounting studies with only phone calls as intervention